OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prophylactic HPV vaccines in patients with HPV-associated diseases and cancer
Miriam Reuschenbach, John Doorbar, Marta del Pino, et al.
Vaccine (2023) Vol. 41, Iss. 42, pp. 6194-6205
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Human Papillomavirus and Associated Cancers: A Review
JaNiese Elizabeth Jensen, Greta L. Becker, J. Brooks Jackson, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 680-680
Open Access | Times Cited: 24

PRGN-2012 gene therapy in adults with recurrent respiratory papillomatosis: a pivotal phase 1/2 clinical trial
Scott M. Norberg, Janet Valdez, Scott Napier, et al.
The Lancet Respiratory Medicine (2025)
Closed Access | Times Cited: 2

The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV)
Fatemeh Movahed, Satinik Darzi, Parya Mahdavi, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 12

Can Vaccines Stop Cancer Before It Starts? Assessing the Promise of Prophylactic Immunization Against High-Risk Preneoplastic Lesions
Tamer A. Addissouky, Ibrahim El Tantawy El Sayed, Majeed M. A. Ali, et al.
Journal of Cellular Immunology (2023) Vol. 5, Iss. 4, pp. 127-140
Open Access | Times Cited: 18

Engineering nanoparticles for cancer immunotherapy: Current achievements, key considerations and future perspectives
Muhammad Umar Farooq, Charles H. Lawrie, Nan‐Nan Deng
Chemical Engineering Journal (2024) Vol. 486, pp. 150356-150356
Closed Access | Times Cited: 7

THE ROLE OF TRANSFORMING GROWTH FACTOR Β IN CERVICAL CARCINOGENESIS
Kleber Paiva Trugilo, Guilherme Cesar Martelossi Cebinelli, Eliza Pizarro Castilha, et al.
Cytokine & Growth Factor Reviews (2024)
Closed Access | Times Cited: 6

Cervical Cancer
Vikrant V. Sahasrabuddhe
Hematology/Oncology Clinics of North America (2024) Vol. 38, Iss. 4, pp. 771-781
Closed Access | Times Cited: 5

Development of an mRNA-based therapeutic vaccine mHTV-03E2 for high-risk HPV-related malignancies
Jing Wang, Qixin Wang, Ling Ma, et al.
Molecular Therapy (2024) Vol. 32, Iss. 7, pp. 2340-2356
Closed Access | Times Cited: 4

Human Papillomavirus (HPV) Vaccination: Progress, Challenges, and Future Directions in Global Immunization Strategies
Francesco Branda, Grazia Pavia, Alessandra Ciccozzi, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1293-1293
Open Access | Times Cited: 4

Investigation of the Potency of KALA and REV Cell‐Penetrating Peptides for In Vitro/In Vivo Delivery of an HPV Multiepitope DNA Construct
Haleh Feyzyab, Alireza Milani, Elnaz Agi, et al.
Journal of Peptide Science (2025) Vol. 31, Iss. 3
Closed Access

Role of infectious agents in Cancer pathogenesis and therapy
Ezichi F. Ofoezie, C Ogbonna, Sandra C. Olisakwe, et al.
The Microbe (2025), pp. 100284-100284
Open Access

Recommendations and Guidance for Human Papillomavirus (HPV) Vaccination for Adults in Taiwan
Kuan‐Yin Lin, I-Fan Lin, Ping-Feng Wu, et al.
Journal of Microbiology Immunology and Infection (2025)
Open Access

HPV Infection in Children and Adolescents—A Comprehensive Review
Paulina Tomecka, Anna Karwowska, Jacek Kuźnicki, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2425-2425
Open Access

Effect of vaccination against HPV in the HPV-positive patients not covered by primary prevention on the disappearance of infection
Pruski Dominik, Millert-Kalińska Sonja, J Robert, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Prophylactic and therapeutic vaccine development: advancements and challenges
Induni Nayodhara Weerarathna, Elijah Skarlus Doelakeh, Lydia Kiwanuka, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 3

History of Human Papilloma Virus Vaccination with a Focus on Italy
Giovanni Gabutti, Matilde Ogliastro
Women (2024) Vol. 4, Iss. 1, pp. 42-52
Open Access | Times Cited: 2

Treatment characteristics, HPV genotype distribution and risk of subsequent disease among women with high-grade cervical intraepithelial neoplasia in Europe: A systematic literature review
Miriam Reuschenbach, Stefano Valente, Jitender Takyar, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology (2024) Vol. 300, pp. 129-140
Open Access | Times Cited: 2

Prophylactic and Therapeutic Cancer Vaccine with Continuous Localized Immunomodulation
Nikitha Kota, Daniel Davila Gonzalez, Hsuan‐Chen Liu, et al.
(2024)
Closed Access

The enigma of the HPV-genital infection in the paediatric and adolescent age (brief communication)
Mihael Skerlev, Suzana Ljubojević Hadžavdić, Slobodna Murat-Sušić, et al.
Liječnički vjesnik (2024) Vol. 146, Iss. Supp 1
Open Access

Response letter to “Understanding the age-related epithelial shifts at the uterine cervix and the area of risk for squamous cell cervical cancer”
Kanan Desai, John Doorbar, Sílvia de Sanjosé, et al.
Preventive Medicine (2024) Vol. 184, pp. 108005-108005
Closed Access

Ovine papillomavirus type 3 virus-like particle-based tools for diagnosis and detection of infection
Carla Cacciotto, Gian Mario Dore, Tiziana Cubeddu, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 126033-126033
Open Access

Page 1 - Next Page

Scroll to top